发布求助
文献互助 智能选刊 最新文献

Immuno-oncology technology最新文献

筛选
英文 中文
24P Blood DNA methylation profiles in NSCLC patients treated with immune checkpoint inhibitors 接受免疫检查点抑制剂治疗的非小细胞肺癌患者血液DNA甲基化谱
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100906
M. Kleinberger , E. Tomasich , J.M. Berger , V. Sunder-Plassmann , L. Gottmann , I. Solano Henao , M. Korpan , J.H. Fürst , C. Englisch , C. Ay , H. Haslacher , J. Furtner , M. Preusser , A.S. Berghoff , G. Heller
{"title":"24P Blood DNA methylation profiles in NSCLC patients treated with immune checkpoint inhibitors","authors":"M. Kleinberger , E. Tomasich , J.M. Berger , V. Sunder-Plassmann , L. Gottmann , I. Solano Henao , M. Korpan , J.H. Fürst , C. Englisch , C. Ay , H. Haslacher , J. Furtner , M. Preusser , A.S. Berghoff , G. Heller","doi":"10.1016/j.iotech.2024.100906","DOIUrl":"10.1016/j.iotech.2024.100906","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100906"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6MO Single-cell analysis of peripheral blood mononuclear cells reveals therapy outcomes are associated with pre-existing immunity in patients treated with oncolytic adenovirus armed with TNFα and IL2 6MO外周血单个核细胞的单细胞分析显示，使用TNFα和il - 2武装的溶瘤腺病毒治疗的患者的治疗结果与预先存在的免疫有关
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100890
T. Kudling , D. Bychkov , J. Clubb , S.A. Pakola , V. Arias , E. Jirovec , M. van der Heijden , N. Ojala , D.C.A. Quixabeira , L. Haybout , K. Jalkanen , T.V. Alanko , R. Havunen , S. Sorsa , C. Kistler , A. Kanerva , O.J. Hemminki , J. Santos , V. Cervera-Carrascon , A. Hemminki
{"title":"6MO Single-cell analysis of peripheral blood mononuclear cells reveals therapy outcomes are associated with pre-existing immunity in patients treated with oncolytic adenovirus armed with TNFα and IL2","authors":"T. Kudling , D. Bychkov , J. Clubb , S.A. Pakola , V. Arias , E. Jirovec , M. van der Heijden , N. Ojala , D.C.A. Quixabeira , L. Haybout , K. Jalkanen , T.V. Alanko , R. Havunen , S. Sorsa , C. Kistler , A. Kanerva , O.J. Hemminki , J. Santos , V. Cervera-Carrascon , A. Hemminki","doi":"10.1016/j.iotech.2024.100890","DOIUrl":"10.1016/j.iotech.2024.100890","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100890"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
67MO Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab in patients with MSS/pMMR locally advanced rectal cancer: A multicentre phase II trial (mRCAT) 67MO保留淋巴结改良短程放疗联合CAPOX和替利单抗治疗MSS/pMMR局部晚期直肠癌：一项多中心II期试验（mRCAT）
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100810
Z. Song , C. Cai , X. Sun , W. Lao , D. Wang , X. Wang , H. Liu , W. Cui , J. Du , M. Chen , H. Wang
{"title":"67MO Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab in patients with MSS/pMMR locally advanced rectal cancer: A multicentre phase II trial (mRCAT)","authors":"Z. Song , C. Cai , X. Sun , W. Lao , D. Wang , X. Wang , H. Liu , W. Cui , J. Du , M. Chen , H. Wang","doi":"10.1016/j.iotech.2024.100810","DOIUrl":"10.1016/j.iotech.2024.100810","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100810"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
76P Fixed 2-year vs. continuous duration immune checkpoint inhibitors in patients diagnosed with advanced cancer: To continue or not to continue? 在诊断为晚期癌症的患者中，固定的2年与连续持续的免疫检查点抑制剂：继续还是不继续？
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100819
M. Smith , M. Robinson , N. Cook , A. O'Reilly
{"title":"76P Fixed 2-year vs. continuous duration immune checkpoint inhibitors in patients diagnosed with advanced cancer: To continue or not to continue?","authors":"M. Smith , M. Robinson , N. Cook , A. O'Reilly","doi":"10.1016/j.iotech.2024.100819","DOIUrl":"10.1016/j.iotech.2024.100819","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100819"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
58P Cardiovascular outcomes of novel CAR-T cell therapies: A meta-analysis of incidence, risk factors, and management of cardiotoxicity 新型CAR-T细胞疗法的心血管结局：发病率、危险因素和心脏毒性管理的荟萃分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100869
H.T. Hashim , A.Q.M. Alhatemi
{"title":"58P Cardiovascular outcomes of novel CAR-T cell therapies: A meta-analysis of incidence, risk factors, and management of cardiotoxicity","authors":"H.T. Hashim , A.Q.M. Alhatemi","doi":"10.1016/j.iotech.2024.100869","DOIUrl":"10.1016/j.iotech.2024.100869","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100869"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
44P Machine learning-based prediction of survival in patients with metastatic renal cell carcinoma receiving first-line immunotherapy 基于机器学习预测接受一线免疫治疗的转移性肾细胞癌患者的生存
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.101004
A. Elgebaly , A. Abdelrahman , G. Abdelkhalek , M. Imam , R. Hammad , H. Abdalla
{"title":"44P Machine learning-based prediction of survival in patients with metastatic renal cell carcinoma receiving first-line immunotherapy","authors":"A. Elgebaly , A. Abdelrahman , G. Abdelkhalek , M. Imam , R. Hammad , H. Abdalla","doi":"10.1016/j.iotech.2024.101004","DOIUrl":"10.1016/j.iotech.2024.101004","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 101004"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
31P Peripheral-blood Immune-predictors of pathological complete response in patients with triple-negative breast cancer undergoing neoadjuvant chemo-immunotherapy 外周血免疫：三阴性乳腺癌接受新辅助化疗免疫治疗患者病理完全缓解的预测因子
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100913
C. Santoro , C. Valenza , G. Pellizzari , G. Antonarelli , D. Trapani , M. Milano , E. Munzone , G. Curigliano
{"title":"31P Peripheral-blood Immune-predictors of pathological complete response in patients with triple-negative breast cancer undergoing neoadjuvant chemo-immunotherapy","authors":"C. Santoro , C. Valenza , G. Pellizzari , G. Antonarelli , D. Trapani , M. Milano , E. Munzone , G. Curigliano","doi":"10.1016/j.iotech.2024.100913","DOIUrl":"10.1016/j.iotech.2024.100913","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100913"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Notice and Disclaimer 通知及免责声明
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/S2590-0188(24)00313-7
{"title":"Notice and Disclaimer","authors":"","doi":"10.1016/S2590-0188(24)00313-7","DOIUrl":"10.1016/S2590-0188(24)00313-7","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 101016"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
96P Comparative cardiovascular risks of PD-1 vs. PD-L1 inhibitors: A meta-analysis of incidence and severity of cardiotoxicity PD-1与PD-L1抑制剂的心血管风险比较：心脏毒性发生率和严重程度的荟萃分析
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100839
M.A. Al-Ghuraibawi , H.T. Hashim , A.Q.M. Alhatemi
{"title":"96P Comparative cardiovascular risks of PD-1 vs. PD-L1 inhibitors: A meta-analysis of incidence and severity of cardiotoxicity","authors":"M.A. Al-Ghuraibawi , H.T. Hashim , A.Q.M. Alhatemi","doi":"10.1016/j.iotech.2024.100839","DOIUrl":"10.1016/j.iotech.2024.100839","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100839"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
22P Extracellular vesicles as predictive biomarkers for chemoimmunotherapy in biliary tract cancer 细胞外囊泡作为胆道肿瘤化疗免疫治疗的预测性生物标志物
Immuno-oncology technology Pub Date : 2024-12-01 DOI: 10.1016/j.iotech.2024.100904
M. Zanoni , S. Bandini , T. Rossi , M. Cortesi , C. Sbrighi , M. Valgiusti , G. La Barba , A. Bittoni , A. Dubini , P. Di Gioia , C. Gallio , L. Esposito , A. Cucchetti , A. Passardi , G. Ercolani , I.G. Rapposelli , P. Ulivi
{"title":"22P Extracellular vesicles as predictive biomarkers for chemoimmunotherapy in biliary tract cancer","authors":"M. Zanoni , S. Bandini , T. Rossi , M. Cortesi , C. Sbrighi , M. Valgiusti , G. La Barba , A. Bittoni , A. Dubini , P. Di Gioia , C. Gallio , L. Esposito , A. Cucchetti , A. Passardi , G. Ercolani , I.G. Rapposelli , P. Ulivi","doi":"10.1016/j.iotech.2024.100904","DOIUrl":"10.1016/j.iotech.2024.100904","url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100904"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信